We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-13.05%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$287B
AUM Growth
-$45.4B
Cap. Flow
+$4.91B
Cap. Flow %
1.71%
Top 10 Hldgs %
16.91%
Holding
3,742
New
162
Increased
2,018
Reduced
1,243
Closed
206

Sector Composition

Rank Sector Weight
1 Technology 19.98%
2 Healthcare 13.1%
3 Financials 12.8%
4 Consumer Discretionary 9.34%
5 Industrials 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVTX icon
3476
Avalo Therapeutics
AVTX
$1.03B
$29K ﹤0.01%
20
-27
-57% -$36.1K
PAYS icon
3477
Paysign
PAYS
$512M
$29K ﹤0.01%
+18,698
New +$31K
PHUN icon
3478
Phunware
PHUN
$43.8M
$29K ﹤0.01%
522
SYBX
3479
DELISTED
Synlogic
SYBX
$29K ﹤0.01%
1,667
TOVX icon
3480
Theriva Biologics
TOVX
$9.64M
$29K ﹤0.01%
+543
New +$31.1K
ATYR
3481
aTyr Pharma
ATYR
$47.1M
$29K ﹤0.01%
10,000
IRD
3482
Opus Genetics
IRD
$317M
$29K ﹤0.01%
+14,928
New +$33.9K
BTCY
3483
DELISTED
Biotricity, Inc. Common Stock
BTCY
$29K ﹤0.01%
2,667
DMK
3484
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$29K ﹤0.01%
804
NMTR
3485
DELISTED
9 Meters Biopharma
NMTR
$29K ﹤0.01%
5,388
-25,491
-83% -$240K
FLUX icon
3486
Flux Power
FLUX
$11.5M
$28K ﹤0.01%
+11,565
New +$28.5K
ENZ
3487
DELISTED
Enzo Biochem, Inc.
ENZ
$28K ﹤0.01%
13,471
TTOO
3488
DELISTED
T2 Biosystems, Inc
TTOO
$28K ﹤0.01%
+34
New +$50.4K
ROI
3489
DELISTED
RiskOn International, Inc. Common Stock
ROI
$28K ﹤0.01%
356
CFMS
3490
DELISTED
Conformis, Inc. Common Stock
CFMS
$28K ﹤0.01%
3,085
USWS
3491
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
$28K ﹤0.01%
+4,816
New +$24.2K
WMC
3492
DELISTED
Western Asset Mortgage Capital Corporation
WMC
$28K ﹤0.01%
2,307
CNVS icon
3493
Cineverse
CNVS
$56M
$27K ﹤0.01%
2,740
PAVM icon
3494
PAVmed
PAVM
$36.2M
$27K ﹤0.01%
64
-370
-85% -$179K
AUMN
3495
DELISTED
Golden Minerals Company
AUMN
$27K ﹤0.01%
+2,986
New +$30.9K
SEEL
3496
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$27K ﹤0.01%
10
-59
-86% -$154K
ENJY
3497
DELISTED
Enjoy Technology, Inc. Common Stock
ENJY
$27K ﹤0.01%
121,860
-46,302
-28% -$54.1K
CRBP icon
3498
Corbus Pharmaceuticals
CRBP
$168M
$26K ﹤0.01%
+3,314
New +$32K
FBIO icon
3499
Fortress Biotech
FBIO
$109M
$26K ﹤0.01%
1,998
-11,300
-85% -$167K
UBX
3500
DELISTED
Unity Biotechnology
UBX
$26K ﹤0.01%
+4,595
New +$38.3K

Similar funds

Charles Schwab's Q2 2022 Portfolio in Review

As of Q2 2022, Charles Schwab held 3,742 positions worth $287B, down 14% from $333B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Charles Schwab's Q2 2022 filing shows 162 new, 2,018 increased, 1,243 reduced and 206 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 435,453 shares worth $44.5M. The largest sale was State Street SPDR Portfolio Short Term Treasury ETF, an estimated $454M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Charles Schwab's largest Q2 2022 buy was iShares 7-10 Year Treasury Bond ETF: 435,453 shares worth $44.5M.
  • Charles Schwab added most to Cisco in Q2 2022, an estimated $554M increase.
  • Charles Schwab's biggest Q2 2022 reduction was State Street SPDR Portfolio Short Term Treasury ETF, cutting an estimated $454M.
  • Charles Schwab fully exited Cerner Corp in Q2 2022, selling an estimated $140M.
  • Charles Schwab's ten largest holdings make up 17% of its $287B portfolio in Q2 2022.
  • Charles Schwab opened 162 new positions and closed 206 in Q2 2022.
  • Charles Schwab's portfolio value fell 14% quarter-over-quarter to $287B.

Based on Charles Schwab's 13F filing for Q2 2022, filed 15 Aug 2022.